510(k) K192028
K192028 is an FDA 510(k) premarket notification submitted by HORIBA ABX SAS for the device "Yumizen C1200 CRP". The FDA issued a decision of Substantially Equivalent on June 25, 2020. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. HORIBA ABX SAS has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 25, 2020
- Date Received
- July 26, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type